HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Hu Selected Research

Antitumor B

8/2015Developing an activity and absorption-based quality control platform for Chinese traditional medicine: Application to Zeng-Sheng-Ping(Antitumor B).
1/2013Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Hu Research Topics

Disease

86Neoplasms (Cancer)
04/2024 - 07/2002
25Infections
05/2024 - 11/2010
22Breast Neoplasms (Breast Cancer)
10/2019 - 06/2007
15COVID-19
12/2022 - 01/2020
14Inflammation (Inflammations)
01/2023 - 05/2007
12Glioma (Gliomas)
01/2023 - 11/2010
10Neoplasm Metastasis (Metastasis)
04/2024 - 01/2006
9Wounds and Injuries (Trauma)
04/2024 - 01/2016
9Body Weight (Weight, Body)
01/2022 - 09/2012
8Diarrhea
02/2024 - 01/2014
8Carcinogenesis
11/2023 - 01/2013
8Hepatocellular Carcinoma (Hepatoma)
01/2023 - 01/2014
7Type 2 Diabetes Mellitus (MODY)
01/2023 - 09/2012
7Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 01/2018
7Pneumonia (Pneumonitis)
08/2021 - 04/2013
6Alzheimer Disease (Alzheimer's Disease)
11/2023 - 01/2012
6Prostatic Neoplasms (Prostate Cancer)
08/2022 - 05/2010
6Glioblastoma (Glioblastoma Multiforme)
01/2019 - 10/2012
6Status Epilepticus (Complex Partial Status Epilepticus)
01/2018 - 03/2014
5Pancreatic Neoplasms (Pancreatic Cancer)
04/2024 - 10/2012
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2016
5Cardiovascular Diseases (Cardiovascular Disease)
08/2023 - 01/2012
5Tuberculosis (Tuberculoses)
08/2023 - 04/2011
5Diabetic Retinopathy (Retinopathy, Diabetic)
04/2022 - 11/2020
5Lung Neoplasms (Lung Cancer)
02/2022 - 05/2007
5Mouth Neoplasms (Oral Cancer)
01/2022 - 01/2013
5Microaneurysm
11/2021 - 01/2017
5Macular Edema
01/2021 - 12/2019
5Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 11/2012
5Carcinoma (Carcinomatosis)
11/2016 - 01/2006
4Stress Urinary Incontinence
04/2024 - 06/2017
4Colonic Neoplasms (Colon Cancer)
04/2024 - 12/2013
4Pain (Aches)
02/2024 - 12/2012
4Burns
02/2024 - 01/2015
4Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2023 - 06/2019
4Hypertension (High Blood Pressure)
12/2022 - 01/2020
4Hypoxia (Hypoxemia)
10/2022 - 01/2018
4Macular Degeneration (Age-Related Maculopathy)
01/2022 - 01/2019
4Critical Illness (Critically Ill)
02/2021 - 10/2020
4Respiratory Insufficiency (Respiratory Failure)
01/2021 - 01/2020
4Alcoholic Fatty Liver
03/2014 - 07/2011
3Sepsis (Septicemia)
04/2024 - 01/2021
3Chronic Obstructive Pulmonary Disease (COPD)
02/2024 - 01/2021
3Retinal Vein Occlusion
06/2023 - 01/2020
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 12/2014
3Reperfusion Injury
10/2022 - 08/2009
3Brain Ischemia (Cerebral Ischemia)
10/2022 - 10/2017
3Ischemia
10/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

46Proteins (Proteins, Gene)FDA Link
01/2023 - 07/2002
13Messenger RNA (mRNA)IBA
01/2023 - 07/2002
11Biomarkers (Surrogate Marker)IBA
06/2023 - 01/2018
11EnzymesIBA
10/2022 - 12/2013
10Retinaldehyde (Retinal)IBA
06/2023 - 01/2017
9Transcription Factors (Transcription Factor)IBA
10/2021 - 06/2011
8ChromatinIBA
04/2024 - 01/2019
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2023 - 11/2012
8Therapeutic UsesIBA
08/2022 - 09/2012
8MicroRNAs (MicroRNA)IBA
02/2022 - 12/2013
8GlucuronidesIBA
12/2018 - 04/2008
7Irinotecan (Camptosar)FDA LinkGeneric
02/2024 - 08/2018
7CytokinesIBA
06/2023 - 01/2018
6Glucose (Dextrose)FDA LinkGeneric
10/2022 - 01/2016
6Ethanol (Ethyl Alcohol)IBA
04/2020 - 07/2011
6Pilocarpine (Ocusert)FDA LinkGeneric
01/2018 - 03/2014
5Anti-Bacterial Agents (Antibiotics)IBA
05/2024 - 03/2017
5Long Noncoding RNAIBA
12/2023 - 01/2021
5afliberceptIBA
11/2021 - 12/2019
5Fluorescein (Funduscein)FDA LinkGeneric
01/2021 - 01/2017
5Polymyxin B (Aerosporin)FDA LinkGeneric
07/2014 - 09/2012
4DNA (Deoxyribonucleic Acid)IBA
04/2024 - 01/2021
4punicalaginIBA
04/2024 - 11/2016
4RNA (Ribonucleic Acid)IBA
01/2023 - 01/2020
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023 - 06/2019
4Triglycerides (Triacylglycerol)IBA
10/2022 - 12/2013
4Cisplatin (Platino)FDA LinkGeneric
08/2022 - 05/2012
4Indicators and Reagents (Reagents)IBA
01/2022 - 01/2003
4Sirtuin 1IBA
01/2022 - 03/2012
4Antiviral Agents (Antivirals)IBA
01/2022 - 01/2017
4Small Interfering RNA (siRNA)IBA
01/2020 - 11/2012
4CollagenIBA
06/2019 - 06/2011
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2023 - 10/2018
3MethyltransferasesIBA
02/2023 - 02/2010
3Insulin (Novolin)FDA Link
01/2023 - 07/2019
3Peptides (Polypeptides)IBA
01/2023 - 04/2017
34-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA
01/2023 - 01/2013
3Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
01/2023 - 02/2012
3AntioxidantsIBA
10/2022 - 04/2015
3Virulence Factors (Pathogenicity Factors)IBA
10/2022 - 01/2022
3ProdrugsIBA
08/2022 - 11/2007
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 01/2021
33-n-butylphthalide (butylphthalide)IBA
01/2022 - 01/2018

Therapy/Procedure

42Therapeutics
04/2024 - 05/2007
13Drug Therapy (Chemotherapy)
01/2024 - 04/2011
7Chemoprevention
11/2023 - 09/2010
6Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 01/2014
5Extracorporeal Membrane Oxygenation
02/2021 - 01/2020
4Length of Stay
01/2024 - 07/2015
4Artificial Respiration (Mechanical Ventilation)
01/2021 - 01/2020
3Secondary Prevention
08/2023 - 01/2018
3Immunotherapy
02/2023 - 01/2018